Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ANI Pharmaceuticals | ANIP | Oct 31, 2024 | 57.24 | -2.16 |
Anika Therapeutics | ANIK | Oct 31, 2024 | 17.11 | -30.67 |
Anixa Biosciences | ANIX | Oct 31, 2024 | 3.50 | -2.51 |
Annaly Capital Management | NLY | Oct 31, 2024 | 19.01 | -1.66 |
Annaly Capital Management F Pref | NLY-F | Oct 31, 2024 | 25.85 | +0.49 |
Annaly Capital Management G Pref | NLY-G | Oct 31, 2024 | 25.54 | +0.16 |
Annaly Capital Management I Pref | NLY-I | Oct 31, 2024 | 25.84 | +0.58 |
Annexon | ANNX | Oct 31, 2024 | 7.32 | -2.92 |
Annovis Bio | ANVS | Oct 31, 2024 | 9.28 | -2.83 |
ANSYS | ANSS | Oct 31, 2024 | 320.41 | -2.48 |
Antelope Enterprise | AEHL | Oct 31, 2024 | 0.33 | -1.40 |
Anterix | ATEX | Oct 31, 2024 | 32.48 | -1.64 |
Antero Midstream | AM | Oct 31, 2024 | 14.37 | -4.20 |
Antero Resources | AR | Oct 31, 2024 | 25.88 | -8.29 |
Anywhere Real Estate | HOUS | Oct 31, 2024 | 3.86 | +2.66 |
Aon | AON | Oct 31, 2024 | 366.87 | -0.70 |
APA | APA | Oct 31, 2024 | 23.60 | +0.55 |
Apartment Investment and Management | AIV | Oct 31, 2024 | 8.44 | -1.52 |
Apellis Pharmaceuticals | APLS | Oct 31, 2024 | 27.26 | -1.62 |
APi Group | APG | Oct 31, 2024 | 34.14 | +2.80 |
Apogee Enterprises | APOG | Oct 31, 2024 | 74.84 | -1.34 |
Apogee Therapeutics | APGE | Oct 31, 2024 | 52.04 | -5.21 |
Apollo Commercial Real Estate Finance | ARI | Oct 31, 2024 | 8.89 | -0.34 |
Apollo Global Management | APO | Oct 31, 2024 | 143.26 | -1.78 |
Apollomics A | APLM | Oct 31, 2024 | 0.12 | -6.60 |
AppFolio A | APPF | Oct 31, 2024 | 207.87 | -4.48 |
Appian A | APPN | Oct 31, 2024 | 35.75 | +1.27 |
Apple | AAPL | Oct 31, 2024 | 225.91 | -1.82 |
Apple Hospitality REIT | APLE | Oct 31, 2024 | 14.77 | -3.15 |
Applied Digital | APLD | Oct 31, 2024 | 6.76 | -8.15 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.